A Mitochondrial Autophagy‐Synthesis Dynamic Equilibrium Liposome for the Repair of Energy Metabolism in Acute Kidney Injury
Advanced Healthcare Materials · 05.11.2026
DOI: 10.1002/adhm.71904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.11.2026. Verfasst von Mengdie Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center For Rehabilitation Medicine, Rehabilitation, & Sports Medicine Research Institute of Zhejiang Province, Zhejiang Provincial People's Hospital …. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute kidney injury (AKI) is a clinical syndrome primarily attributed to mitochondrial dysfunction, characterized by disrupted mitochondrial balance. Impaired biogenesis leads to insufficient energy supply, while defective autophagy results in the accumulation of damaged mitochondria‐both of which exacerbate injury to renal tubular epithelial cells. In this study, we developed melatonin/pioglitazone liposomes (MP@Lip) for AKI therapy via restoration of mitochondrial dynamic balance. When melatonin and pioglitazone was jointly delivered to damaged renal tubules, they activated mitochondrial autophagy and biogenesis, thereby bidirectionally restoring mitochondrial network homeostasis. Mechanistically, AMPK/SIRT3/PGC‐1α‐related signaling may be involved in the mitochondrial protection of MP@Lip. Upon AMPK phosphorylation, SIRT1/SIRT3 deacetylase activity is upregulated, the ratio of LC3B‐II/LC3B‐I increases, p62/SQSTM1 decreases, and autophagy is enhanced. PGC‐1α enhances transcriptional activity and promotes the expression of mitochondrial biogenic markers (TOM20). This complementary degradation‐synthesis loop gradually restores mitochondrial dynamic balance. In vitro experiments confirmed that MP@Lip reduces ROS production and apoptosis while restoring mitochondrial membrane potential. In vivo studies demonstrated improvement in renal function indicators, alleviation of inflammatory responses and histopathological damage, and no systemic toxicity. This strategy shifts AKI treatment from symptomatic support to ameliorating mitochondrial dysfunction, providing a targeted, complementary and relatively safe approach that may be applicable to other mitochondrial functional‐related diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center For Rehabilitation Medicine, Rehabilitation, & Sports Medicine Research Institute of Zhejiang Province, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zh…
ORCID-Profile: Mengdie Yu, Zhangwei Yan, Wenying Yu, Xiaozhou Mou, Yu Cai
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yu, M., Yan, Z., Zhao, J., Wang, L., Yang, X., Liao, X., Yu, W., Mou, X., & Cai, Y. (2026). A Mitochondrial Autophagy‐Synthesis Dynamic Equilibrium Liposome for the Repair of Energy Metabolism in Acute Kidney Injury. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71904
Vancouver
Yu M, Yan Z, Zhao J, Wang L, Yang X, Liao X, et al. A Mitochondrial Autophagy‐Synthesis Dynamic Equilibrium Liposome for the Repair of Energy Metabolism in Acute Kidney Injury. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71904
BibTeX
@article{Yu2026,
author = {Yu, Mengdie and Yan, Zhangwei and Zhao, Jiamei and Wang, Lvjing and Yang, Xuelian and Liao, Xinhai and Yu, Wenying and Mou, Xiaozhou and Cai, Yu},
title = {A Mitochondrial Autophagy‐Synthesis Dynamic Equilibrium Liposome for the Repair of Energy Metabolism in Acute Kidney Injury},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71904}
}
EUVIMED